Gros David-Alexandre C 4
4 · Eledon Pharmaceuticals, Inc. · Filed May 2, 2023
Insider Transaction Report
Form 4
Gros David-Alexandre C
DirectorChief Executive Officer
Transactions
- Award
Common Stock (right to buy)
2023-05-01+383,299→ 383,299 totalExercise: $2.30Exp: 2033-05-01→ Common Stock (383,299 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase up to 383,299 shares of Common Stock, which option vests with respect to 95,825 shares on May 1, 2024, and then with respect to 6.25% of the underlying shares quarterly over the three-year period ending May 1, 2027.